Novavax
American biotechnology company
Novavax ▸ Facts ▸ Comments ▸ News ▸ Videos
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases. During 2020, the company redirected its efforts to focus on development and approval of its NVX-CoV2373 vaccine for COVID-19.
| 0 shares | ShareTweetSavePostSend |
You Might Like
WHO approves SII's Covovax for emergency useCovavax is the Indian version of the Novavax vaccine brought in India by the Serum Institute of India for children.DNA - Published |
| Search this site and the web: |
